MEDP vs LH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
MEDP · Medpace$653.11 ▲ 2.86%
LH · Labcorp Holdings$366.57 ▲ 0.90%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- MEDP +8.8%
- LH +41.8%
Head to head
| Metric | MEDP | LH |
|---|---|---|
| Price | $653.11 | $366.57 |
| Change today | ▲ 2.86% | ▲ 0.90% |
| Market cap | $18.27B | $29.77B |
| Return, 3 months | +8.4% | +14.3% |
| Return, year to date | +16.3% | +47.2% |
| Return, 1 year | +10.9% | +46.5% |
| P/E (TTM) | 36.3 | 30.0 |
| P/B | 31.2 | 3.4 |
| P/E percentile vs own 5y | 75th | 75th |
| Dividend yield | – | 0.79% |
| Revenue growth (YoY, latest qtr) | +8.5% | +6.9% |
| Net profit growth (YoY) | +23.7% | +0.6% |
| Gross margin | 29.1% | 29.0% |
| Operating margin | 21.4% | 11.3% |
| Net margin | 18.2% | 6.9% |
| Return on equity | 117.9% | 11.4% |
| Analyst target vs. price | +5.8% | +6.7% |
| Analyst buy share | 38% | 91% |
| RSI (14) | 53 | 70 |
| 30-day volatility | 36.6% | 31.4% |
| Max drawdown, 1 year | -36.6% | -13.4% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- LH is the largest of the group by market value.
- LH has returned the most over the past year.
- LH carries the lowest trailing P/E.
- MEDP is growing revenue fastest.
- MEDP keeps the most profit per dollar of sales.
- LH has been the calmest stock over the last 30 days.